The independent source for health policy research, polling, and news.
Showing 1 - 20 of 110
President Donald Trump’s immigration crackdown in Minneapolis forced families into hiding and catalyzed informal medical networks to deliver critical health care services.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
The CDC is recommending fewer childhood vaccines, although the ones it has jettisoned from the recommended schedule have successfully battled serious illness for years. Experts warn that if vaccine uptake falls, millions could be hospitalized — or worse — as a result of preventable diseases.
A session of a vaccine panel dominated by skeptics was chaotically at odds with past practices of the CDC, which HHS Secretary Robert F. Kennedy Jr. has described as a “cesspool of corruption.” His crew voted to end a 34-year recommendation to vaccinate newborns against hepatitis B.
A reshaped CDC website suggesting that vaccines cause autism has appalled the medical community.
Drug industry officials and analysts praised the FDA’s plans to streamline regulation of “biosimilars,” which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S. market are getting harder to fight.
Florida’s surgeon general, spiritual healers, and Trump allies push their cures in a swampy outpost of anti-government absolutism and mystical belief.
Florida has announced plans to end mandatory vaccination. Now scientists are assessing which of several diseases deadly to children — whooping cough, measles, polio, rubella, mumps, diphtheria, and tetanus — are likely to make a resurgence and when.
A Centers for Disease Control and Prevention meeting on vaccines pitted scientific expertise against vaccine skepticism. An often confusing debate ended with critics of the current vaccine schedule tabling a vote to remove one of its cornerstones.
A lack of faith in the soundness of the Centers for Disease Control and Prevention’s new direction has led states to explore enacting their own vaccine policies. A patchwork of divergent recommendations and requirements could result.
Susan Monarez and former Centers for Disease Control and Prevention chief medical officer Debra Houry described turmoil in an agency dominated by anti-vaccine political officials nominated by Health and Human Services Secretary Robert F. Kennedy Jr.
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
The National Institutes of Health’s long-held standard of peer review for grantmaking has been subverted by President Donald Trump and NIH Director Jay Bhattacharya, who gave unprecedented power to politicos, NIH workers say.
Xlear, a maker of xylitol gum, has sued the Federal Trade Commission, saying the onus should be on government to prove that ingredients don’t live up to advertised claims. RFK Jr.’s “medical freedom” allies have rallied to the cause.
After spearheading a 34% cut in cancer mortality, the National Cancer Institute at the NIH is bleeding resources and staff and could see its budget cut by nearly 40%.
A new vaccine advisory panel appointed by the HHS secretary, a longtime anti-vaccine activist, reflected his unsupported claims about the safety of childhood inoculations.
Vaccines are under fire from the top of the Trump administration. Federal programs to monitor them and make them safer have always been underfunded.
Worried that President Donald Trump’s FDA might not act, a panel of cancer experts recommended that doctors consider testing before dosing patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.
While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.
Secretary Robert F. Kennedy Jr.’s HHS said an enormous, noncompetitive flu vaccine development grant to two favored NIH leaders would ensure “transparency, effectiveness, and comprehensive preparedness.” But their vaccine is in early stages, relies on old technology, and is just one of scores of similar efforts.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF